Kyung Nam Pharm Co.,Ltd. (KOSDAQ:A053950) announced that private placement of 389,105 common shares at an issue price of KRW 5,140 for gross proceeds of KRW 1,999,999,700 on March 30, 2020. The transaction will involve participation from returning investor BioGenetics CO.,LTD. (KOSDAQ:A044480).The securities issued in the transaction have a hold period of one year, post the closing of the transaction. The shares issued in the transaction have a face value of 500 per share.

The company will raise funds through third party allocation method. The payment date is May 6, 2020.